What are the treatment options for squamous cell non–small cell lung cancer (NSCLC) in patients with EGFR mutations?

Updated: Jul 15, 2021
  • Author: Winston W Tan, MD, FACP; Chief Editor: Nagla Abdel Karim, MD, PhD  more...
  • Print

For patients with metastatic squamous cell lung cancer it is important to test for EGFR mutation. If EGFR mutation is present, chemotherapy with cisplatin and gemcitabine and necitumumab should be prescribed. Other options could include oral EGFR inhibitors.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!